Literature DB >> 30190809

No one should die of melanoma: a vision or impossible mission?

Iris Zalaudek1,1, Elvira Moscarella2,2, Caterina Longo2,2, Aimilios Lallas2,2, Giuseppe Argenziano2,2, Rainer Hofmann-Wellenhof1,1.   

Abstract

While the incidence of early-stage melanoma has dramatically increased over the past decades, the incidence and mortality rates of thick melanomas have remained relatively stable during the same period. A number of alternative theories have been postulated in order to explain these divergent trends between thin and thick melanomas, among which is the question of whether nodular melanoma may originate in the dermis. This concept has gained support from recent improvements in the understanding of the origin of melanocytes and the morphological and molecular diversity of melanoma. A dermal origin would plausibly explain why efforts at improving the early detection of melanoma largely fail, as it implies an initially intradermal growth that is hidden from our eyes until clinical signs and symptoms become only secondarily apparent. In light of this, at the current stage, the vision that no one should die of melanoma is an impossible mission.

Entities:  

Keywords:  diagnosis; epidemiology; melanoma; melanomagenesis; screening

Year:  2014        PMID: 30190809      PMCID: PMC6094643          DOI: 10.2217/mmt.14.12

Source DB:  PubMed          Journal:  Melanoma Manag        ISSN: 2045-0885


  43 in total

1.  No one should die of malignant melanoma.

Authors:  A B Ackerman
Journal:  J Am Acad Dermatol       Date:  1985-01       Impact factor: 11.527

Review 2.  Superficial spreading and nodular melanoma are distinct biological entities: a challenge to the linear progression model.

Authors:  Holly S Greenwald; Erica B Friedman; Iman Osman
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

3.  Historical, clinical, and dermoscopic characteristics of thin nodular melanoma.

Authors:  Sara Kalkhoran; Olivia Milne; Iris Zalaudek; Susana Puig; Josep Malvehy; John W Kelly; Ashfaq A Marghoob
Journal:  Arch Dermatol       Date:  2010-03

4.  Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry.

Authors:  Alan C Geller; Richard W Clapp; Arthur J Sober; Lou Gonsalves; Lloyd Mueller; Cindy L Christiansen; Waqas Shaikh; Donald R Miller
Journal:  J Clin Oncol       Date:  2013-09-16       Impact factor: 44.544

5.  Can noninvasive imaging tools potentially predict the risk of ulceration in invasive melanomas showing blue and black colors?

Authors:  Caterina Longo; Francesca Farnetani; Elvira Moscarella; Barbara de Pace; Silvana Ciardo; Giovanni Ponti; Simonetta Piana; Anna M Cesinaro; Carlo Cota; Giuseppe Argenziano; Cliff Rosendahl; Giovanni Pellacani; Iris Zalaudek
Journal:  Melanoma Res       Date:  2013-04       Impact factor: 3.599

Review 6.  Cutaneous melanoma--atypical variants and presentations.

Authors:  Alex Chamberlain; Jonathan Ng
Journal:  Aust Fam Physician       Date:  2009-07

7.  Increasing burden of melanoma in the United States.

Authors:  Eleni Linos; Susan M Swetter; Myles G Cockburn; Graham A Colditz; Christina A Clarke
Journal:  J Invest Dermatol       Date:  2009-01-08       Impact factor: 8.551

8.  Expression patterns of MITF during human cutaneous embryogenesis: evidence for bulge epithelial expression and persistence of dermal melanoblasts.

Authors:  Briana C Gleason; Christopher P Crum; George F Murphy
Journal:  J Cutan Pathol       Date:  2008-02-29       Impact factor: 1.587

9.  Nestin expression is associated with aggressive cutaneous melanoma of the nodular type.

Authors:  Rita G Ladstein; Ingeborg M Bachmann; Oddbjørn Straume; Lars A Akslen
Journal:  Mod Pathol       Date:  2013-09-13       Impact factor: 7.842

Review 10.  The melanoma epidemic: res ipsa loquitur.

Authors:  Frederick C Beddingfield
Journal:  Oncologist       Date:  2003
View more
  1 in total

1.  A nomogram for predicting survival in patients with nodular melanoma: A population-based study.

Authors:  Jin Yang; Zhenyu Pan; Fanfan Zhao; Xiaojie Feng; Qingqing Liu; Yuanjie Li; Jun Lyu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.